Aemetis (AMTX) Expected to Release Earnings on Thursday

Key Points

• Aemetis is expected to report Q3 2026 results before the market opens on Thursday, November 5, with analysts forecasting a loss of $0.20 per share and revenue of $74.20 million. The earnings call is scheduled for 2:00 p.m. ET.
• In its prior quarter, Aemetis reported a loss of $0.13 per share, beating estimates for a $0.29 loss, but revenue of $62.70 million fell short of the $67.69 million consensus estimate.
• The stock opened at $1.30 and remains near its 52-week low, while analyst sentiment is mixed: the consensus rating is Hold, with one Buy and one Sell rating and a consensus price target of $11.88.

Aemetis (NASDAQ:AMTX - Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Aemetis to announce earnings of ($0.20) per share and revenue of $74.20 million for the quarter. Investors may visit the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 2:00 PM ET.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.16. The firm had revenue of $62.70 million during the quarter, compared to analysts' expectations of $67.69 million. On average, analysts expect Aemetis to post ($0.89) EPS for the current fiscal year and ($0.48) EPS for the next fiscal year.

Aemetis Stock Down 0.8%

NASDAQ AMTX opened at $1.30 on Thursday. The stock has a market capitalization of $93.82 million, a P/E ratio of -1.43 and a beta of 1.82. Aemetis has a 52-week low of $1.18 and a 52-week high of $3.80. The firm has a 50-day moving average price of $1.74 and a 200 day moving average price of $1.95.

Analyst Ratings Changes

AMTX has been the topic of several recent analyst reports. Weiss Ratings reiterated a "sell (e+)" rating on shares of Aemetis in a research report on Thursday, October 15th. Wall Street Zen raised Aemetis from a "sell" rating to a "hold" rating in a report on Saturday, August 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $11.88.

About Aemetis

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company's California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.